|
Zylox-Tonbridge Medical Tech Co Ltd is a medical device company established in 2012 that develops and commercializes interventional devices for peripheral and neurovascular applications. The company’s product portfolio includes peripheral vascular interventional devices such as stents, balloon catheters, and thrombus aspiration catheters, as well as neurovascular devices including flow diverters, embolization coils, and intracranial stents. Key products include the Thrombite Clot Retriever Device, Penguin Peripheral Venous Stent System, Kylin Flow Diverter, and Mammoth Large Lumen Peripheral Thrombus Aspiration Catheter. The company serves hospitals and physicians in China and international markets, with production bases in China and Germany. It has formed strategic partnerships with Avinger for OCT solutions, Hicicare for vascular guidewires, and Wire Sciences for surgical robotics. The company acquired Optimed to expand its global supply chain and distribution network. Many of its products have received the NMPA Innovative Medical Device designation. Summarised from the company's own disclosures, fiscal year ended Apr 2026 |
Industry Medical Devices | Homepage zyloxtb.com |
| Sector Healthcare | IR page zyloxtb.com/investor-relations | |
|
Tags
peripheral vascular devices, neurovascular devices, stents, balloon catheters, thrombus aspiration, flow diverters, embolization coils, vascular access, ischemic stroke, hemorrhagic stroke, atherectomy, intracranial stents, Thrombite Clot Retriever Device, Penguin Peripheral Venous Stent System, Kylin Flow Diverter, Mammoth Large Lumen Peripheral Thrombus Aspiration Catheter, Orca Balloon Expandable Covered Stent, Otter Thrombectomy Catheter, Self-expandable Aneurysm Embolization Device, OCT-guided Peripheral Vascular Targeted Atherectomy Catheter Series, ZYLOX Venous Stent System, Tonbridge Gekko Coil System, Tonbridge Gycline Microcatheter, Zynlastic peripheral venous stent system, ZYLOX Octoplus IVC Filter, ZENFlow Tiger LD PTA Dilatation Catheter, ZYLOX Phoenix Peripheral Detachable Fibered Coil Embolization System, ZYLOX Unicorn Vascular Closure Device, Pantheris Atherectomy Device, ZENFluxion, ZENFLEX Pro, ZENFLEX Peripheral Stent System, Optimed, Avinger, Hicicare, Wire Sciences, SKY ROAD
|
Press page — |
Metrics
| Valuation | |
|---|---|
| Market cap | HK$ 5.68B |
| Market cap (USD) | $ 723.868M |
| P/E | 20.57 |
| PEG | — |
| P/BV | 1.60 |
| P/S | 4.00 |
| P/OCF | 10.40 |
| P/FCF | — |
| Dividend yield | 1.4% |
| Turnover / mcap | 0.16% |
| Returns | |
|---|---|
| ROE | 7.2% |
| ROI | 7.0% |
| ROIC | 7.0% |
| Profit margin | 21.7% |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | Yes |
| Revenue up 3y | Yes |
| Revenue up 5y | Yes |
| Earnings growth 3y (net profit CAGR) | — |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | Yes |
| Buying back stock | No |
| Diluting (TTM) | No |
| Debt/Equity | 3.7% |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 0 |
| Quality score | 41.2% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpAnnouncements and reports published on HKEXnews, newest first, monthly and next-day returns, proxy forms and board-meeting notices included. The link opens the announcement on HKEXnews. Press releases from the company's own website, newest first.
Table of Content [Hide
]
Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK) has received CE Mark certification under the European Union Medical Device Regulation (EU MDR) for two of its neurovascular products, the Kylin™ Flow Diverter and the Gekko™ Detachable Coil System.
The certifications expand Zylox-Tonbridge's neurovascular portfolio in Europe and pave the way for commercialization across the 27 EU member states. They also mark another step in the company's international expansion, supporting its efforts to bring more treatment options to physicians and patients worldwide.
-
Kylin™ Flow Diverter
The Kylin™ Flow Diverter features a braided design using platinum-core nitinol DFT wires for enhanced visibility during deployment. Its closed, flared distal end facilitates smooth, controlled opening and supports precise positioning. Since its launch in China in 2024, Kylin™ has been used in more than 10,000 clinical cases, including over 3,000 involving distal small vessels.
-
Gekko™ Detachable Coil System
The Gekko™ Detachable Coil System features an ultra-soft design for gentle placement within the aneurysm. Its mechanical detachment mechanism enables rapid, reliable coil release without the need for a separate detachment device, simplifying the procedure for physicians.
With EU MDR CE Mark certification secured for both products, Zylox-Tonbridge plans to advance their commercialization in Europe and strengthen collaboration with local physicians and partners to support clinical adoption based on local clinical needs.
The company will continue to expand its international operations and strengthen its global competitiveness as it advances its strategy to build a global vascular intervention platform, bringing innovative treatment options to more physicians and patients worldwide.
PREV:
Zylox-Tonbridge Delivers Strong First-Half 2026 Results as International Revenue Surges 349%
NEXT: No information
Return
References
Related Neurovascular Device Products
ZYLOX Octoplus™ Vena Cava Filter
Thrombite™ II Clot Retriever Device
ZYLOX Unicorn™ Vascular Closure Device
Stay informed with the latest company news from Zylox-Tonbridge.
TonBridge Medical won the Science and Technology Innovation Leader of 2020 and Science and Technology Innovation Product of 2020 Explore More >
Regional Distribution of the Neurovascular Devices Market Explore More >
Global Market Analysis for Neurovascular Interventions Explore More >
+86-571-8861-0082
[email protected]
Zylox-Tonbridge Industrial Park, No. 270 Shuyun Road, Yuhang District, Hangzhou, Zhejiang, China
Ischemic Stroke Hemorrhagic Stroke Intracranial Stenosis Carotid Artery Stenosis Intracranial Access Radial Artery Access
Arterial Venous Hemodialysis Access Other Peripheral-Vascular Vascular Closure Devices
Quick Links
About ESG Patients Investor Relations News Contact Us
Copyright © ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. All Rights Reserved.
Ischemic Stroke Hemorrhagic Stroke Intracranial Stenosis Carotid Artery Stenosis Intracranial Access Radial Artery Access
Arterial Venous Hemodialysis Access Other Peripheral-Vascular Vascular Closure Devices
Quick Links
About ESG Patients Investor Relations News Contact Us
Zylox-Tonbridge Industrial Park, No. 270 Shuyun Road, Yuhang District, Hangzhou, Zhejiang, China
[email protected] +86-571-8861-0082
Copyright © ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. All Rights Reserved.
We use cookies on this site, including third party cookies, to delivery experience for you.
Accept Cookies
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding Zylox-Tonbridge Medical Tech Co Ltd.
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.












